Vishakha Singh
Roorkee, UL 247667, India
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 40 publications
Bioengineered chimeric VLPs targeting chikungunya virus and SARS-CoV-2 show high immunogenicity in mice.
Journal: Biochemical and biophysical research communications
Published: October 25, 2025
Mechanistic Insights Into the Inhibition of Dengue Virus NS5 Methyltransferase by Herbacetin.
Journal: Proteins
Published: August 02, 2025
A novel molecule inhibits SARS-CoV-2 RBD binding to the ACE2 receptor, blocks viral entry and exhibits antiviral activity in a murine model.
Journal: Archives of virology
Published: July 27, 2025
Designing and bioengineering of CDRs with higher affinity against receptor-binding domain (RBD) of SARS-CoV-2 Omicron variant.
Journal: International journal of biological macromolecules
Published: September 18, 2024
Structure-based identification of herbacetin and caffeic acid phenethyl ester as inhibitors of S-adenosylmethionine-dependent viral methyltransferase.
Journal: FEBS letters
Published: September 08, 2024
Structure-guided mutations in CDRs for enhancing the affinity of neutralizing SARS-CoV-2 nanobody.
Journal: Biochemical and biophysical research communications
Published: June 01, 2024
A novel framework based on explainable AI and genetic algorithms for designing neurological medicines.
Journal: Scientific reports
Published: February 29, 2024
A comprehensive overview of CRISPR/Cas 9 technology and application thereof in drug discovery.
Journal: Journal of cellular biochemistry
Published: April 24, 2022
Antimicrobial and anti-viral effects of selenium nanoparticles and selenoprotein based strategies: COVID-19 and beyond.
Journal: Journal of drug delivery science and technology
Published: February 09, 2022
Gene therapy: Comprehensive overview and therapeutic applications.
Journal: Life sciences
Published: December 17, 2021
Last Updated: 09/26/2026